
Chinese General Practice ›› 2018, Vol. 21 ›› Issue (36): 4429-4433.DOI: 10.12114/j.issn.1007-9572.2018.00.217
Special Issue: 内分泌代谢性疾病最新文章合辑
• Monographic Research • Previous Articles Next Articles
Published:2018-12-20
Online:2018-12-20
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2018.00.217
| [1]ABALOVICH M,AMINO N,BARBOUR L A,et al.Management of thyroid dysfunction during pregnancy and postpartum:an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2007,92(8 Suppl):S1-47.DOI:10.1210/jc.2007-0141. [2]MOLETI M,TRIMARCHI F,VERMIGLIO F.Thyroid physiology in pregnancy[J].Endocr Pract,2014,20(6):589-596.DOI:10.4158/EP13341.RA. [3]叶元华,李静,詹瑛,等.脂肪和胎盘组肿瘤坏死因子-α表达与妊娠期糖尿病胰岛素抵抗的相关性研究[J].中华围产医学杂志,2007,10(1):24-28.DOI:10.3760/cma.j.issn.1007-9408.2007.01.007. [4]GAO X L,YANG H X,ZHAO Y.Variations of tumor necrosis factor-α,leptin and adiponectin in mid-trimester of gestational diabetes mellitus[J].Chin Med J(Engl),2008,121(8):701-705. [5]谢洪.瘦素水平对于预测妊娠期糖尿病的临床价值研究[J].中国妇幼卫生杂志,2016,7(1):30-33. [6]BITTERMAN O,BONGIOVANNI M,GIULIANI C,et al.Anti thyroperoxidase and anti thyroglobulin antibodies in diabetic pregnancies[J].J Endocrinol Invest,2014,37(10):911-915.DOI:10.1007/s40618-014-0087-4. [7] PHILIPS J C,EMONTS P,PINTIAUX A,et al.Management of gestational diabetes[J].Rev Med Liege,2013,68(9):489-496. [8]SCHNEIDER S,BOCK C,WETZEL M,et al.The prevalence of gestational diabetes in advanced economies[J].J Perinat Med,2012,40(5):511-520.DOI:10.1515/jpm-2012-0015. [9]TUTINO G E,TAM W H,YANG X,et al.Diabetes and pregnancy:perspectives from Asia[J].Diabet Med,2014,31(3):302-318.DOI:10.1111/dme.12396. [10]KIM C,NEWTON K M,KNOPP R H.Gestational diabetes and the incidence of type 2 diabetes:a systematic review[J].Diabetes Care,2002,25(10):1862-1868. [11]BELLAMY L,CASAS J P,HINGORANI A D.Type 2 diabetes mellitus after gestational diabetes:a systematic review and meta-analysis[J].Lancet,2009,373(9677):1773-1779.DOI:10.1016/S0140-6736(09)60731-5. [12]NERENBERG K,DASKALOPOULOU S S,DASGUPTA K.Gestational diabetes and hypertensive disorders of pregnancy as vascular risk signals:an overview and grading of the evidence[J].Can J Cardiology,2014,30(7):765-773.DOI:10.1016/j.cjca.2013.12.030. [13]张娅,徐先明.妊娠期糖尿病病因学研究进展[J].中国实用妇科与产科杂志,2013,29(4):299-302. [14]中华医学会内分泌学分会,中华医学会围产医学分会.妊娠和产后甲状腺疾病诊治指南[J].中华内分泌代谢杂志,2012,28(5):354-371. [15]GUDOVIC A,SPREMOVIC-RADJENOVIC S,LAZOVIC G,et al.Maternal autoimmune thyroid disease and pregnancy complication[J].Vojnosanit Pregl,2010,67(8):617-621. [16]王巧敏,刘怀昌,李蕊,等.甲状腺功能减退对妊娠期糖尿病孕妇糖代谢及胰岛素敏感性的影响[J].广东医学,2016,37 (2):245-246.DOI:10.13820/j.cnki.gdyx.2016.02.020. [17]吉卉.甲状腺功能减退对妊娠期糖尿病影响的研究[D].天津:天津医科大学,2013. [18]MAO H,LI Q,GAO S.Meta-analysis of the relationship between common type 2 diabetes risk gene variants with gestational diabetes mellitus[J].PLoS One,2012,7(9):e45882.DOI:10.1371/journal.pone.0045882. [19] ZHANG C,BAO W,RONG Y,et al.Genetic variants and the risk of gestational diabetes mellitus:a systematic review[J].Hum Reprod Update,2013,19(4):376-390.DOI:10.1093/humupd/dmt013. [20]MORRIS A P,VOIGHT B F,TESLOVICH T M,et al.Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes[J].Nat Genet,2012,44(9):981-990.DOI:10.1038/ng.2383. [21]BASILE K J,JOHNSON M E,XIA Q,et al.Genetic susceptibility to type 2 diabetes and obesity:follow-up of findings from genome-wide association studies[J].Int J Endocrinol,2014:769671.DOI:10.1155/2014/769671. [22]MOHLKE K L,BOEHNKE M.Recent advances in understanding the genetic architecture of type 2 diabetes[J].Hum Mol Genet,2015,24(1):R85-92.DOI:10.1093/hmg/ddv264. [23]MULDER H,NAGORNY C L,LYSSENKO V,et al.Melatonin receptors in pancreatic islets:good morning to a novel type 2 diabetes gene[J].Diabetologia,2009,52(7):1240-1249.DOI:10.1007/s00125-009-1359-y. [24]PESCHKE E,MUEHLBAUER E.New evidence for a role of melatonin in glucose regulation[J].Best Pract Res Clin Endocrinol Metab,2010,24(5):829-841.DOI:10.1016/j.beem. [25]STANCAKOVA A,KUULASMAA T,PAANANEN J,et al.Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release,proinsulin conversion,and insulin sensitivity in 5,327 nondiabetic Finnish men[J].Diabetes,2009,58(9):2129-2136.DOI:10.2337/db09-0117. [26]GROENEWOUD M J,DEKKER J M,FRITSCHE A,et al.Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps[J].Diabetologia,2008,51(9):1659-1663.DOI:10.1007/s00125-008-1083-z. [27] IRWIN D M,TAN H.Evolution of glucose utilization:glucokinase and glucokinase regulator protein[J].Mol Phylogenet Evol,2014,70:195-203.DOI:10.1016/j.ympev.2013.09.016. [28]ULLRICH S,SU J,RANTA F,et al.Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells[J].Pflugers Arch,2005,451(3):428-436.DOI:10.1007/s00424-005-1479-2. [29]DIMAS A S,LAGOU V,BARKER A,et al.Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity[J].Diabetes,2014,63(6):2158-2171.DOI:10.2337/db13-0949. [30]LIN J D,YANG S F,WANG Y H,et al.Associations of melatonin receptor gene polymorphisms with Graves' disease[J].PLoS One,2017,12(9):e0185529.DOI:10.1371/journal.pone.0185529. [31] R?NN T,WEN J,YANG Z,et al.A common variant in MTNR1B,encoding melatonin receptor 1B,is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals[J].Diabetologia,2009,52(5):830-833.DOI:10.1007/s00125-009-1297-8. [32] NAKAMURA E,KOZAKI K,TSUDA H,et al.Frequent silencing of putative tumor suppressor gene melatonin receptor 1 A(MTNR1A) in oral squamous-cell carcinoma[J].Cancer Sci,2008,99(7):1390-1400.DOI:10.1111/j.1349-7006.2008.00838.x. [33]LI C,QIAO B,ZHAN Y,et al.Association between genetic variations in MTNR1A and MTNR1B genes and gestational diabetes mellitus in Han Chinese women[J].Gynecol Obstet Invest,2013,76(4):221-227.DOI:10.1159/000355521. [34]JEON E J,HONG S Y,LEE J H.Adipokines and insulin resistance according to characteristics of pregnant women with gestational diabetes mellitus[J].Diabetes Metab J,2017,41(6):457-465.DOI:10.4093/dmj.2017.41.6.457. [35]赖丽萍,陆泽元,李翠吟,等.孕晚期妊娠期糖尿病脂联素、瘦素与胰岛素抵抗的相关性[J].实用预防医学,2012,19(8):1135-1137. [36]ORTEGA-SENOVILLA H,SCHAEFER-GRAF U,MEITZNER K,et al.Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood[J].Diabetes Care,2011,34(9):2061-2066.DOI:10.2337/dc11-0715. [37]LAMBADIARI V,MITROU P,MARATOU E,et al.Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes[J].Endocrine,2011,39(1):28-32.DOI:10.1007/s12020-010-9408-3. [38]PRATS-PUIG A,SITJAR C,RIBOT R,et al.Relative hypoadiponectinemia,insulin resistance,and increased visceral fat in euthyroid prepubertal girls with low-normal serum free thyroxine[J].Obesity,2012,20(7):1455-1461.DOI:10.1038/oby.2011.206. [39]白宇,赖亚新,李静,等.PTU诱导大鼠低甲状腺素血症与胰岛素抵抗相关[J].中国医科大学学报,2015,44(1):27-29,33. [40]MUELLER A,SCHOFL C,DITTRICH R,et al.Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome[J].Hum Reprod,2009,24(11):2924-2930.DOI:10.1093/humrep/dep285. [41]QIU C,SORENSEN T K,LUTHY D A,et al.A prospective study of maternal serum C-reactive protein(CRP) concentrations and risk of gestational diabetes mellitus[J].Paediatr Perinat Epidemiol,2004,18(5):377-384.DOI:10.1111/j.1365-3016.2004.00578.x. [42]赖亚新,王浩宇,范晨玲,等.促甲状腺激素对大鼠脂肪组织中瘦素,脂联素,TNF-α 及 IL-6 表达水平的影响[J].山东医药,2015,55(13):1-3.DOI:10.3969/j.issn.1002-266X.2015.13.001. [43] 卢敏,王英,陈青,等.炎性及脂肪细胞因子与妊娠期糖尿病发病的相关性及在产褥期的变化[J].中国妇幼保健,2012,47(6):436-439. [44] OH E S,HAN J H,HAN S M,et al.Adipokine concentrations in pregnant Korean women with normal glucose tolerance and gestational diabetes mellitus[J].Korean Diabetes J,2009,33(4):279-288.DOI :10.4093/kdj.2009.33.4.279. [45]于健,王炎,马金秀,等.妊娠期糖尿病患者血清瘦素水平与胰岛素抵抗的关系[J].中华糖尿病杂志,2005,13(3):172-173. [46]丰雪,樊淑华,于学静,等.甲状腺功能减退症患者血清内脂素和瘦素水平及意义[J].黑龙江医药科学,2016,39(1):87-91. [47] 林清兰,林晓岚,麦尚敏.妊娠期糖尿病孕妇甲状腺功能及甲状腺自身抗体的变化[J].广东医学,2014,35(9):1355-1356.DOI:10.13820/j.cnki.gdyx.2014.09.023. [48]PASCUAL C E,ANDRADA P.Is autoimmune thyroid dysfunction a risk factor for gestational diabetes? [J].Endocrinol Nutr,2014,61(7):377-381.DOI:10.1016/j.endonu.2014.01.009. [49] CHEN L M,ZHANG Q,SI G X,et al.Associations between thyroid autoantibody status and abnormal pregnancy outcomes in euthyroid women[J].Endocrine,2015,48(3):924-928.DOI:10.1007/s12020-014-0420-x. [50] 赵瑛,刘小庆,苏阳,等.妊娠糖尿病和糖尿病合并妊娠患者的甲状腺功能与抗体的变化分析[J].中国地方病防治杂志,2013,28(3):232-233. [51] NEGRO R,SCHWARTZ A,GISMONDI R,et al.Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes[J].J Clin Endocrinol Metab,2011,96(6):E920-924.DOI:10.1210/jc.2011-0026. [52] TOULIS K A,STAGNARO-GREEN A,NEGRO R.Maternal subclinical hypothyroidsm and gestational diabetes mellitus:a meta-analysis[J].Endocr Pract,2014,20(7):703-714.DOI:10.4158/EP13440.RA. [53] KARAKOSTA P,ALEGAKIS D,GEORGIOU V A,et al.Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes[J].J Clin Endocrinol Metab,2012,97(12):4464-4472.DOI:10.1210/jc.2012-2540. [54] 史晓光,韩成,李晨嫣,等.妊娠早期妇女甲状腺自身抗体分析[J].中华内分泌代谢杂志,2016,32(5):376-379.DOI:10.3760/cma.j.issn.1000-6699.2016.05.005. [55] YANG S,SHI F T,LEUNG P C,et al.Low thyroid hormone in early pregnancy is associated with an increased risk of gestational diabetes mellitus[J].J Clin Endocrinol Metab,2016,101(11):4237-4243.DOI:10.1210/jc.2016-1506. [56] OLIVIERI A,VALENSISE H,MAGNANI F,et al.High frequency of antithyroid autoantibodies in pregnant women at increased risk of gestational diabetes mellitus[J].Eur J Endocrinol,2000,143(6):741-747. [57] GONG L L,LIU H,LIU L H.Relationship between hypothyroidism and the incidence of gestational diabetes:a meta-analysis[J].Taiwan J Obstet Gynecol,2016,55(2):171-175.DOI:10.1016/j.tjog.2016.02.004. [58] REZZONICO J,NIEPOMNISZCZE H,REZZONICO M,et al.The association of insulin resistance with subclinical thyrotoxicosis[J].Thyroid,2011,21(9):945-949.DOI:10.1089/thy.2010.0402. [59]康苏娅,汪云,伍理.妊娠期糖尿病孕妇甲状腺功能及妊娠结局的研究[J].现代妇产科进展,2014,23(1):50-52.DOI:10.13283/j.cnki.xdfckjz.2014.01.039. [60]朱雨霏,赖亚新,姜凤伟,等.亚临床甲状腺功能减退症患者及甲状腺功能正常者甲状腺功能与血糖水平的关系[J].中华糖尿病杂志,2012,4(3):139-143.DOI:10.3760/cma.j.issn.1674-5809.2012.03.004. [61]李天惠.妊娠期亚临床甲状腺功能减退患者血糖代谢的变化分析[J].临床医学研究与实践,2016,1(14):122-123.DOI:10.19347/j.cnki.2096-1413.2016.14.091. |
| [1] | WANG Yang, ZHAO Shiting, CHEN Yingying, SUN Zilin, QIU Shanhu. Key Points of Exercise Intervention and Implementation for People with Complications of Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(21): 2989-2994. |
| [2] | LI Jiawei, GAO Xinyi, GE Aoqi, LI Juanjuan, YUAN Beibei. Demand and Associated Factors for Integrated Medical Care and Preventive Services among Patients with Type 2 Diabetes [J]. Chinese General Practice, 2026, 29(21): 3028-3039. |
| [3] | PAN Ziyun, YIN Hao, LIN Zhirou, MAO Jingyi, HUANG Yan, LUO Yanhua, XIAO Jiafu, HU Yin. From Mechanism to Therapy: Diabetic Autonomic Neuropathy [J]. Chinese General Practice, 2026, 29(21): 2982-2988. |
| [4] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [5] | GE Dan, WANG Zhi, DING Qun, GUO Tonglan, XU Tongdao. Relationship between Remnant Cholesterol and Non-alcoholic Fatty Liver Disease as well as Progressive Liver Fibrosis in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(20): 2854-2859. |
| [6] | ZHANG Xiaojuan, LIU Yang, PENG Bo, YE Yuan, ZHU Kun. Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital [J]. Chinese General Practice, 2026, 29(19): 2614-2620. |
| [7] | JIAN Yingchun, ZENG Yongqin, ZHANG Haiping, WANG Zhengdi, AN Ke, YAN Rui. Recent Advances in Mitochondrial Dysfunction in Chronic Metabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2577-2584. |
| [8] | MIAO Jingjie, ZHANG Jinwen, WU Qianhao, HAN Peipei. Research Advances on the Effects of Intermittent Fasting on Cardiometabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2538-2545. |
| [9] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [10] | LI Menglin, DING Fang, QIAN Yu, PU Dong, DU Qianqian, GUAN Tianhang, HE Yilin. Study on Glycemic Control Status and Influencing Factors among Community Diabetic Patients [J]. Chinese General Practice, 2026, 29(17): 2334-2339. |
| [11] | SUN Xibin, LI Jiawei, GE Aoqi, YUAN Beibei. The Association between the Specialists Outreach and the Job Perception and Diabetes Management Competence of Primary Care Providers [J]. Chinese General Practice, 2026, 29(17): 2319-2325. |
| [12] | CHEN Jiali, ZHANG Jingjing, WANG Hexia, TANG Xiaorui, WU Yujie, LEI Yang, LIN Zheng. Latent Profile Analysis of Chronic Illness Resource Utilization and Its Impact on Health-promoting Behaviors in Individuals with Prediabetes [J]. Chinese General Practice, 2026, 29(16): 2244-2251. |
| [13] | WANG Rui, LUO Dan, YANG Cuicui, WENG Xinyi, WANG Yubing, XU Jingjing. Complex Network Analysis of Resilience in Adolescents with Type 1 Diabetes Mellitus Based on Multi-sourced Stigma [J]. Chinese General Practice, 2026, 29(16): 2264-2272. |
| [14] | FU Mingyuan, YU Xiaoyi, GE Caiying, KONG Min. Impaired Awareness of Hypoglycemia: Prevalence and Determinants among Community-based Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(16): 2252-2258. |
| [15] | XU Ping, MA Yan, HUANG Li, HE Meiliang, HOU Yunfeng, WANG Dewang, SUN Panpan, LIU Zheng, GUO Yanfang, XU Ying. Association between Weight-adjusted Waist Index and Comorbidity of Hypertension, Diabetes and Dyslipidemia in Community-dwelling Adults [J]. Chinese General Practice, 2026, 29(16): 2198-2204. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||